Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services.

The Yankees cut bullpen acquisition Enyel De Los Santos just two weeks after they acquired him from the San Diego […] Empire Sports Media. Yankees’ pitching acquisition is falling flat on his ...

Acquisition extends ICON’s presence in the market for government sponsored research and enhances capabilities in Vaccines and Infectious Disease. September 19, 2016 06:00 AM ...